Marketing - Clinical Research Informer

Immuno-oncology market set to grow in billions, but access concerns remain

Pharmaceutical Technology

MAY 26, 2023

The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in multiple indications in the past decade. There are currently over 700 immuno-oncology products in Phase I-III of development in the eight major markets, said Chalk.

Marketing

Marketing Vaccination Vaccine Antibody

Why DTC isn’t, and is, marketing

World of DTC Marketing

AUGUST 10, 2022

CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism. But, in pharma marketing, the changes affect every product category. However, DTC marketing is different, much different. So what’s the opportunity for DTC marketers?

Marketing

Marketing Drugs Vaccination Vaccine

Current and future players in the lupus market

Pharmaceutical Technology

JANUARY 23, 2023

As such, the SLE and LN marketplace is dominated by generics, and GSK’s Benlysta and AstraZeneca’s Saphnelo are the only drugs that have gained marketing approval specifically for SLE in more than 50 years. In previous years, Benlysta has managed to grow the lupus market in terms of value, having generated approximately $492.9m

Marketing

Marketing Drugs Antibody Trials

EC grants marketing authorisation for Sandoz’s biosimilar Hyrimoz

Pharmaceutical Technology

APRIL 3, 2023

The European Commission (EC) has granted marketing authorisation for Sandoz’s biosimilar Hyrimoz (adalimumab) citrate-free high-concentration formulation (HCF). With eight marketed biosimilars, Sandoz is offering the broadest biosimilar portfolio and is the leading biosimilars company in Europe, with more than two decades of experience.

Marketing

Marketing Medicine Antibody Trials

Takeda discontinuing in AAV and rare haematology disease markets

Pharmaceutical Technology

APRIL 13, 2023

With challenges around the R&D, clinical trials, pricing, and market access for these rare disease therapeutics, big pharma often collaborates with specialist biotechnology companies as a method of de-risking the development of gene therapy products.

Gene Therapy

Gene Therapy Gene In-Vivo Marketing

EMA validates Sobi’s marketing authorisation application for efanesoctocog alfa

Pharmaceutical Technology

MAY 22, 2023

The European Medicines Agency (EMA) has accepted and verified Sobi’s marketing authorisation application for a new factor VIII (FVIII), efanesoctocog alfa, to treat haemophilia A patients of all ages.

Marketing

Marketing Genetics Trials Medicine

The Mexico pharma market: growth factors and advantages for manufacturing

Pharmaceutical Technology

DECEMBER 15, 2022

Mexico is Latin America’s second-largest pharmaceutical market and ranks in the top 15 on the global list of biggest pharma markets. Furthermore, the Mexican market typically favors branded products over generics, making the country a highly suitable location to license innovative medicines. million has coverage.

Manufacturing

Manufacturing Clinical Trials Clinical Trials Marketing

Is biotech facing a long bear market?

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7.

Marketing

Marketing Gene Therapy Pharma Companies Gene

Risk sharing agreements soar as market access risk increases

Pharmaceutical Technology

MARCH 17, 2023

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. Thus, a higher risk score reflects a more hostile market access environment and drug launch in a geographical area.

Marketing

Marketing Drugs Pharma Companies Research Analyst

Kamada’s Glassia receives marketing authorisation from Swissmedic

Pharmaceutical Technology

MAY 17, 2023

Biopharmaceutical company Kamada has received marketing authorisation from Swissmedic for human alpha1-proteinase inhibitor Glassia to treat Alpha-1 antitrypsin deficiency (AATD) in Switzerland. The therapy was also approved in several other international markets, including Brazil, Russia, Argentina, and Israel.

Marketing

Marketing Medicine Drugs Production

Influencer marketing in pharma

World of DTC Marketing

JANUARY 12, 2022

The word influencer was added to the Merriam-Webster dictionary in 2019, but influencer marketing is nothing new. Scandals, fake followers, bot technologies, and the pandemic crisis converged have put a halt to influencer marketing growth and tarnished the public view of influencers as a whole. billion in 2021.

Marketing

Marketing Drugs Branding Production

HCPs sound off on pharma marketing

World of DTC Marketing

APRIL 20, 2022

We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. This was especially true with new drugs that have a significant competitive market. Will they transform their HCP marketing or stick to dated models?

Marketing

Marketing Drug Trials Drugs Trials

Why hasn’t pharma embraced email marketing?

World of DTC Marketing

MARCH 9, 2021

SUMMARY : DTC marketers are spending tens of millions of dollars on programmatic ads that are full of fraud and have low click-through rates but they have yet to embrace email marketing which has an average click-through rate of 3.43%. The key to effective email marketing is segmentation and personalization.

Marketing

Marketing Compliance Branding Packaging

DTC marketers addicted to TV

World of DTC Marketing

APRIL 21, 2022

I can get better results using digital laser targeting and targeted print ads, but DTC marketers are like TV because it makes them feel important within their company. ” Marketers were tapped to develop a model that showed the patient’s journey to getting an Rx. The post DTC marketers addicted to TV.

Marketing

Marketing Drugs Development Branding

DTC Marketing strategy must be fluid

World of DTC Marketing

APRIL 19, 2022

Before most drugs are launched, much time and effort are spent developing marketing plans and getting approval. However, given the rapid changes in the market and the realization that too many tactics are more hype than reality, fixed marketing plans are a waste of time. This all leads to a new model in DTC marketing.

Marketing

Marketing Branding Drugs Production

Racing to the finish line: help for reducing risks, ensuring security and driving faster speed-to-market

Bio Pharma Dive

MAY 22, 2023

When pharma manufacturers are racing to bring a new product to market, catastrophic printing errors and mislabeled materials can have a significant impact on timelines and budgets.

Marketing

Marketing Manufacturing Production

EC announces EU pharma reform that cuts market exclusivity

Pharmaceutical Technology

APRIL 27, 2023

The European Commission’s (EC) long-anticipated pharma reform plans in the European Union have finally been unveiled , indicating a focus on improving access to medicines across the bloc while cutting down on market exclusivity.

Medicine

Medicine Clinical Trials Clinical Trials Marketing

DTC marketing is an oxymoron

World of DTC Marketing

APRIL 22, 2021

QUICK READ: More TV DTC spots are airing, but DTC marketers are losing the battle between awareness and conversion because of all the noise online. I’ve spent the last six months analyzing clients’ DTC marketing campaigns and they are, for most ineffective. One of the most underused tactics is your product website.

Marketing

Marketing Drugs Doctors Doctor

BioCryst gains marketing authorisation for Orladeyo in Chile

Pharmaceutical Technology

MAY 23, 2023

BioCryst Pharmaceuticals has secured marketing authorisation from the Public Health Institute (ISP) of Chile for oral, once-daily ORLADEYO (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) attacks in patients aged 12 years and above.

Marketing

Marketing Drugs Development

CHMP recommends full marketing approval for Gilead Sciences’ Hepcludex

Pharmaceutical Technology

MAY 5, 2023

The European Medicines Agency’s (EMA) committee for medicinal products for human use (CHMP) has recommended full marketing authorisation (MA) for Gilead Sciences ’ Hepcludex (bulevirtide) to treat chronic hepatitis delta virus (HDV) and compensated liver disease in adult patients.

Marketing

Marketing Medicine Drugs Trials

Unmet needs in the obesity market

Pharmaceutical Technology

APRIL 13, 2023

The obesity therapeutics market has considerable unmet needs. GlobalData’s recent Obesity: Seven-Market Drug Forecast and Market Analysis report explores several of the unmet needs in this disease space. Another significant unmet need in the obesity market is the availability and accessibility of specialists.

Marketing

Marketing Clinical Trials Clinical Trials Drugs

A new era of pharma marketing?

World of DTC Marketing

MAY 17, 2022

Communication and transparency are vital to building trust, which necessitates a shift away from traditional DTC marketing. If pharma is going to leap to a new era of marketing, they have to get to know their audiences. The post A new era of pharma marketing? Let’s back up a second, though. 3hree: Engage your customers.

Pharma Companies

Pharma Companies Marketing Drugs Branding

The four biggest challenges facing DTC marketers

World of DTC Marketing

APRIL 6, 2022

DTC marketing has evolved. Challenge #1 – DIGITAL MARKETING. Pharma companies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. Paid Media – The most commonly used KPI in marketing is essentially worthless.

Marketing

Marketing Pharma Companies Doctors Doctor

The Brazilian pharma market: Key information and what may change

Pharmaceutical Technology

DECEMBER 9, 2022

Brazil is the largest country in Latin America, with a population of over 212 million, and consequently has the biggest pharmaceutical market in the region. Advantages of joining PIC/S include the adoption of codes that should reduce the number of audits required for some products, accelerating their time to market.

Marketing

Marketing Medicine Drugs Licensing

Omnichannel marketing is the answer but what’s the question?

World of DTC Marketing

NOVEMBER 16, 2021

SUMMARY: Omnichannel marketing employs the simultaneous implementation of channels across personal, non-personal, and media and addresses the integrated needs of multiple stakeholders – consumers/patients, healthcare professionals, and payers. Today there are microsegments of markets, and one message shouldn’t be used for all.

Marketing

Marketing Pharma Companies Doctors Doctor

Y-mAbs’ Danyelza injection receives marketing approval in Brazil

Pharmaceutical Technology

MAY 24, 2023

Y-mAbs Therapeutics has received marketing authorisation for Danyelza (naxitamab-gqgk) 40mg/10mL injection from the Brazilian Health Regulatory Agency, Agência Nacional de Vigilância Sanitária, to treat high-risk neuroblastoma. The therapy is given three times a week and repeated every four weeks.

Marketing

Marketing Antibody Drugs Licensing

EMA accepts Sandoz’s marketing applications for biosimilar denosumab

Pharmaceutical Technology

MAY 26, 2023

The European Medicines Agency (EMA) has accepted two marketing authorisation applications (MAA) from Sandoz for the proposed biosimilar denosumab. The MAAs include all indications covered by the Xgeva (denosumab) and Prolia (denosumab) reference medicines to treat conditions such as osteoporosis in postmenopausal women.

Clinical Trials

Clinical Trials Clinical Trials Medicine Marketing

How pharma digital marketing can excel

World of DTC Marketing

AUGUST 9, 2020

Pharma digital marketing has been lagging behind key trends for a long while. Let’s face it, pharma organizations are not made for speed while digital marketing is all about “now” Digital marketing is also about experimentation and learning from successes as well as failures.

Marketing

Marketing Branding Development

The debate on DTC marketing is going to heat up again

World of DTC Marketing

JULY 21, 2021

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The voices in Washington DC are once again calling for a moratorium on DTC marketing but lawmakers need to understand what DTC marketing actually does as upped to what people believe it does. DTC ads raise awareness around health conditions.

Drugs

Drugs Marketing Doctors Doctor

Why online marketing is so essential for pharma

World of DTC Marketing

MAY 31, 2022

There’s quite a debate in the CPG world about the investment in digital marketing. However, with pharma brands, online is essential to a successful marketing strategy. For this reason, digital marketing is an essential part of any pharma brand. Suppose pharma is to leap into being great at digital marketing.

Marketing

Marketing Pharma Companies Pharma Production Doctors

Apellis receives validation of marketing applications for pegcetacoplan

Pharmaceutical Technology

APRIL 24, 2023

Apellis Pharmaceuticals has received validation of its four marketing applications for intravitreal pegcetacoplan by regulatory authorities in Switzerland, the UK, Canada and Australia. The marketing applications are based on the data obtained from the Phase III OAKS and DERBY trials at 24 months.

Marketing

Marketing Trials Drugs Regulation

The biggest transformation in pharma marketing since DTC

World of DTC Marketing

JANUARY 26, 2022

This is an exciting time to be in healthcare marketing. We’re witnessing the most significant transformation in healthcare marketing since DTC was approved in the ’90s. is no more an option but the critical factor to ensure success for any multichannel marketing initiatives. What about telehealth?

Pharma Companies

Pharma Companies Marketing Drugs Doctors

Marketing to physicians

World of DTC Marketing

MAY 13, 2021

More specifically, the data revealed 75 percent of physicians do not trust the information provided to them by those marketers. It’s been my experience that measuring HCP marketing is easier than measuring DTC marketing, and great HCP marketing may actually do more to support brand objectives than DTC spots.

Marketing

Marketing Pharma Companies Drugs Doctors

UK’s MHRA grants marketing approval for Akebia’s Vafseo to treat CKD

Pharmaceutical Technology

MAY 23, 2023

The UK’s medicines and healthcare products regulatory agency (MHRA) has granted marketing authorisation for Akebia Therapeutics’ Vafseo (vadadustat) to treat symptomatic anaemia associated with chronic kidney disease (CKD) in adult patients on chronic maintenance dialysis.

Clinical Trials

Clinical Trials Clinical Trials Marketing Trials

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing

Manufacturing Pharma Companies Marketing Vaccination

Entrance of novel therapies will drive Niemann-Pick type C disease market growth

Pharmaceutical Technology

JULY 26, 2022

According to GlobalData’s recent Niemann-Pick Type C (NPC): Opportunity Analysis and Forecast to 2031 report, the NPC market is expected to see significant growth during 2021–31. This sales growth will be in line with a steadily increasing disease prevalence and the entrance of novel agents into the market.

Marketing

Marketing Gene Clinical Development Drugs

Gilead receives EC marketing authorisation for HIV treatment in children

Pharmaceutical Technology

NOVEMBER 30, 2022

Gilead Sciences has received the European Commission’s (EC) expanded marketing authorisation for Biktarvy (bictegravir 30mg / emtricitabine 120mg / tenofovir alafenamide 15mg tablets) for treating human immunodeficiency virus (HIV) infection in virologically suppressed children.

FDA Approval

FDA Approval Clinical Trials Clinical Trials Marketing

PharmaEssentia picks Pint-Pharma to market BESREMi in Latin America

Pharmaceutical Technology

JUNE 5, 2023

Pint-Pharma will obtain and maintain all marketing authorisations and will commercialise BESREMi in the region. The companies have entered into an exclusive licence agreement to register and promote BESREMi to treat polycythemia vera (PV), a rare type of blood cancer, in Ecuador, Chile, Mexico, Argentina, Brazil, Colombia and Peru.

Marketing

Marketing Medicine Drugs Licensing

Biogen and Eisai seek UK’s marketing authorisation for lecanemab

Pharmaceutical Technology

MAY 22, 2023

Biogen and Eisai have submitted a marketing authorisation application (MAA) to the UK’s medicines and healthcare products regulatory agency (MHRA) for lecanemab to treat early Alzheimer’s disease (AD).

Antibody

Antibody Marketing Drugs Trials

Obesity market expected to reach $37.1bn across 7MM by 2031

Pharmaceutical Technology

MARCH 28, 2023

The obesity market is expected to grow at a compound annual growth rate (CAGR) of 31.3% over the course of the forecast period, reaching $37.1bn across the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK and Japan) according to GlobalData’s recent report, Obesity: Seven-Market Drug Forecast and Market Analysis.

Marketing

Marketing Clinical Trials Clinical Trials Drugs

Aurinia’s Lupkynis receives marketing authorisation from Swissmedic

Pharmaceutical Technology

MAY 3, 2023

Aurinia Pharmaceuticals has received marketing authorisation from the Swiss Agency for Therapeutic Products (Swissmedic) for Lupkynis (voclosporin), along with a background immunosuppressive therapy.

Marketing

Marketing Drugs Medicine Licensing

Duopharm to market Luye Pharma’s cholesterol management product in Malaysia

Pharmaceutical Technology

APRIL 5, 2023

Luye Pharma Group has signed a marketing and distribution agreement with Duopharma Biotech’s wholly-owned subsidiary, Duopharma Marketing, for a cholesterol management product in Malaysia. Both the companies are targeting a double-digit compound annual growth rate for the product in the local market over the next ten years.

Production

Production Marketing Medicine Drugs

Market cap downturn hits over half of top 20 biopharmaceutical companies in Q1 2023

Pharmaceutical Technology

MAY 16, 2023

More than half of the top 20 global biopharmaceutical companies saw a fall in market capitalisation over Q1 2023. decline in total aggregate market capitalisation from $3.61 Bayer reported the highest market capitalisation growth of 23.1% Sanofi and Regeneron’s market capitalisation grew by 12.4% This resulted in a 3.4%

Generic Drugs

Generic Drugs FDA Approval Drugs Marketing

For biotechs to attract investors think like marketers

World of DTC Marketing

FEBRUARY 15, 2022

Biotechs need to think like marketers to cut through the noise and attract investors. CEOs have to think like marketers to cut through the clutter with all the biotech startups out there. The post For biotechs to attract investors think like marketers appeared first on World of DTC Marketing.com.

Clinical Trials

Clinical Trials Clinical Trials Marketing Drugs

Immuno-oncology market set to grow in billions, but access concerns remain

Why DTC isn’t, and is, marketing

Trending Sources

Current and future players in the lupus market

EC grants marketing authorisation for Sandoz’s biosimilar Hyrimoz

Takeda discontinuing in AAV and rare haematology disease markets

EMA validates Sobi’s marketing authorisation application for efanesoctocog alfa

The Mexico pharma market: growth factors and advantages for manufacturing

Is biotech facing a long bear market?

Risk sharing agreements soar as market access risk increases

Kamada’s Glassia receives marketing authorisation from Swissmedic

Influencer marketing in pharma

HCPs sound off on pharma marketing

Why hasn’t pharma embraced email marketing?

DTC marketers addicted to TV

DTC Marketing strategy must be fluid

Racing to the finish line: help for reducing risks, ensuring security and driving faster speed-to-market

EC announces EU pharma reform that cuts market exclusivity

DTC marketing is an oxymoron

BioCryst gains marketing authorisation for Orladeyo in Chile

CHMP recommends full marketing approval for Gilead Sciences’ Hepcludex

Unmet needs in the obesity market

A new era of pharma marketing?

The four biggest challenges facing DTC marketers

The Brazilian pharma market: Key information and what may change

Omnichannel marketing is the answer but what’s the question?

Y-mAbs’ Danyelza injection receives marketing approval in Brazil

EMA accepts Sandoz’s marketing applications for biosimilar denosumab

How pharma digital marketing can excel

The debate on DTC marketing is going to heat up again

Why online marketing is so essential for pharma

Apellis receives validation of marketing applications for pegcetacoplan

The biggest transformation in pharma marketing since DTC

Marketing to physicians

UK’s MHRA grants marketing approval for Akebia’s Vafseo to treat CKD

Brazil: untapped market for big pharma manufacturing

Entrance of novel therapies will drive Niemann-Pick type C disease market growth

Gilead receives EC marketing authorisation for HIV treatment in children

PharmaEssentia picks Pint-Pharma to market BESREMi in Latin America

Biogen and Eisai seek UK’s marketing authorisation for lecanemab

Obesity market expected to reach $37.1bn across 7MM by 2031

Aurinia’s Lupkynis receives marketing authorisation from Swissmedic

Duopharm to market Luye Pharma’s cholesterol management product in Malaysia

Market cap downturn hits over half of top 20 biopharmaceutical companies in Q1 2023

For biotechs to attract investors think like marketers

Stay Connected